New Research: BPC-157 and TB-500 Aid Tendon Repair in Rats — but Combining Them Adds Nothing

The BPC-157 + TB-500 combination vial on this site is described as a common research pairing rather than a validated single mechanism — investigators studying tissue-repair pathways often compare or combine the two peptides in the same injury model to see whether the effects are additive or simply redundant. A study published this month in the Journal of Joint Diseases and Related Surgery puts that exact question to a direct test in a rat Achilles tendon repair model, and the answer is more nuanced than “combining is better.”

The study design

Researchers in Turkey performed standardized Achilles tendon transection and repair surgery on 32 rats, then randomly assigned the animals to four groups: an untreated control group, BPC-157 alone, TB-500 alone, and a combined BPC-157 + TB-500 group. Treatments were given daily for four weeks after surgery. At the end of that period, tendons were evaluated two ways — biomechanically, by measuring the maximum load the repaired tendon could bear before failing, and histologically, using several staining methods and two standard scoring systems (Bonar and Movin scores) to assess tendon architecture, collagen alignment, and degenerative changes. The researchers also used immunohistochemistry to quantify collagen type I and type III expression, the two collagen types most relevant to how a healing tendon rebuilds its structural matrix.

What the study found

TB-500 alone produced the clearest signal across both types of measurement. It was the only group to reach statistical significance on the biomechanical test, with repaired tendons bearing significantly more load before failing than controls. It also showed significantly better histological scores on both the Bonar and Movin systems, indicating more organized tendon architecture and fewer degenerative changes. BPC-157 alone trended in the same direction on histology — numerically better scores than controls — but didn’t reach statistical significance on its own. Sirius red staining, which visualizes collagen organization, showed increased type I collagen organization in the treatment groups generally, most notably in the TB-500 group, consistent with a tendon progressing further toward mature matrix structure.

The part worth sitting with: no additive effect

The combined BPC-157 + TB-500 group did not outperform either peptide given alone. The authors note this directly: combination therapy conferred no additional benefit over TB-500 or BPC-157 individually, despite the biological rationale for pairing two peptides that are each proposed to act on tissue-repair and angiogenic pathways. Their proposed explanation is that the two peptides may converge on shared downstream signaling pathways, so administering both doesn’t provide two independent routes to a better outcome — it may simply be hitting the same target twice. The authors are careful to frame this as a hypothesis that needs further experimental confirmation, not a settled mechanistic explanation.

What this means for tendon-repair research

This is a single exploratory rat study, not a clinical trial, and the authors describe their own findings as preliminary — the dosing wasn’t optimized between the individual and combined arms, and the four-week endpoint captures early-phase repair rather than long-term outcomes. But it’s a useful data point specifically because it tests the additive-effect question directly rather than assuming it. For anyone researching this specific combination, the practical takeaway from this study is that the rationale for pairing BPC-157 with TB-500 — probing complementary rather than redundant pathways — didn’t hold up under this particular experimental design, at least not at four weeks. TB-500 alone was the standout single agent here, which is itself worth noting given how often the two peptides are discussed as a pair in the research literature.

Further reading

• Biçer O, Adanir O, Güleryüz Y, et al. “Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.” Journal of Joint Diseases and Related Surgery, 2026;37(3):822-837. PubMed: 42542926 · doi.org/10.52312/jdrs.2026.2951